Sn Bioscience

Developer of a nanoparticle-based drug-delivery system for cancer treatment

placeSeoul, Seoul, South Korea calendar_todayFounded 2017 groups24 employees language snbioscience.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 160 times.

YearFilings
20211
20231
20241

Investor mix

3 investors on record.

Investor typeCountShare
Accelerator & incubator267%
Other / undisclosed133%
Coming soon